Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

Plus Library

By pinki@katapult.biz / February 13, 2025

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 2,201 - 2,225 of 2,875

«
1
…
87
88
89
90
91
…
115
»

CAR-T Cells and Other Cell Based Therapies

CAR-T Cells and Other Cell Based Therapies

Mehrdad Abedi - MD

CAR-T Cells and Other Cell Based Therapies

CAR-T Cells and Other Cell Based Therapies

Mehrdad Abedi, MD

Non Hodgkin & Hodgkin Lymphomas

Non Hodgkin & Hodgkin Lymphomas

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

CAR-T Cell Therapy in Lymphomas: 7-Years Later

CAR-T Cell Therapy in Lymphomas: 7-Years Later

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

CAR-T Cell Therapy in Lymphomas: 7-Years Later

CAR-T Cell Therapy in Lymphomas: 7-Years Later

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Follicular Lymphoma: Novel Advances and Pathways

Follicular Lymphoma: Novel Advances and Pathways

Nahkle Saba, MD

Follicular Lymphoma: Novel Advances and Pathways

Follicular Lymphoma: Novel Advances and Pathways

Nahkle Saba, MD

Follicular Lymphoma: When to Start Therapy and How To Decide The Optimal Treatment?

Follicular Lymphoma: When to Start Therapy and How To Decide The Optimal Treatment?

Nakhle S. Saba, MD

New Approaches for Follicular Lymphoma

New Approaches for Follicular Lymphoma

Nakhle S. Saba, MD

New Approaches for Follicular Lymphoma

New Approaches for Follicular Lymphoma

Nakhle S. Saba, MD

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

Nakhle Saba, MD

Follicular Lymphoma and CLL Updates 2023

Follicular Lymphoma and CLL Updates 2023

Nakhle Saba, MD

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

Nakhle Saba, MD

Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy

Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy

Nakhle Saba, MD

Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy

Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy

Nakhle Saba, MD

Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Rafael Mestres, MD

CLL/Lymphoma Updates in 2024

CLL/Lymphoma Updates in 2024

Robert Emmons, MD

Marginal Zone Lymphomas

Marginal Zone Lymphomas

Sameh Gaballa, MD

New Therapies for Follicular Lymphoma

New Therapies for Follicular Lymphoma

Sameh Gaballa, MD

Marginal Zone Lymphomas

Marginal Zone Lymphomas

Sameh Gaballa, MD

New Therapies for Follicular Lymphoma

New Therapies for Follicular Lymphoma

Sameh Gaballa, MD

«
1
…
87
88
89
90
91
…
115
»

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok